Skip to main content
Top
Published in: Population Health Metrics 1/2022

Open Access 01-12-2022 | Chronic Kidney Disease | Research

Trends and patterns of disparities in diabetes and chronic kidney disease mortality among US counties, 1980–2014

Authors: Ali H. Mokdad, Laura Dwyer-Lindgren, Amelia Bertozzi-Villa, Rebecca W. Stubbs, Chloe Morozoff, Shreya Shirude, Sam B. Finegold, Charlton Callender, Mohsen Naghavi, Christopher J. L. Murray

Published in: Population Health Metrics | Issue 1/2022

Login to get access

Abstract

Introduction

Diabetes and chronic kidney diseases are associated with a large health burden in the USA and globally.

Objective

To estimate age-standardized mortality rates by county from diabetes mellitus and chronic kidney disease.

Design and setting

Validated small area estimation models were applied to de-identified death records from the National Center for Health Statistics (NCHS) and population counts from the census bureau, NCHS, and the Human Mortality Database to estimate county-level mortality rates from 1980 to 2014 from diabetes mellitus and chronic kidney disease (CKD).

Exposures

County of residence.

Main outcomes and measures

Age-standardized mortality rates by county, year, sex, and cause.

Results

Between 1980 and 2014, 2,067,805 deaths due to diabetes were recorded in the USA. The mortality rate due to diabetes increased by 33.6% (95% UI: 26.5%–41.3%) between 1980 and 2000 and then declined by 26.4% (95% UI: 22.8%–30.0%) between 2000 and 2014. Counties with very high mortality rates were found along the southern half of the Mississippi river and in parts of South and North Dakota, while very low rates were observed in central Colorado, and select counties in the Midwest, California, and southern Florida. A total of 1,659,045 deaths due to CKD were recorded between 1980 and 2014 (477,332 due to diabetes mellitus, 1,056,150 due to hypertension, 122,795 due to glomerulonephritis, and 2,768 due to other causes). CKD mortality varied among counties with very low mortality rates observed in central Colorado as well as some counties in southern Florida, California, and Great Plains states. High mortality rates from CKD were observed in counties throughout much of the Deep South, and a cluster of counties with particularly high rates was observed around the Mississippi river.

Conclusions and relevance

This study found large inequalities in diabetes and CKD mortality among US counties. The findings provide insights into the root causes of this variation and call for improvements in risk factors, access to medical care, and quality of medical care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Murray CJL, et al. Five insights from the global burden of disease study 2019. The Lancet. 2020;396(10258):1135–59.CrossRef Murray CJL, et al. Five insights from the global burden of disease study 2019. The Lancet. 2020;396(10258):1135–59.CrossRef
2.
go back to reference Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1204–23.CrossRef Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1204–23.CrossRef
3.
go back to reference Wang H, et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1160–12034.CrossRef Wang H, et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1160–12034.CrossRef
5.
go back to reference Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.CrossRef Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.CrossRef
6.
go back to reference Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286(10):1195–200.CrossRef Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286(10):1195–200.CrossRef
7.
go back to reference Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol. 1997;146(3):214–22.CrossRef Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol. 1997;146(3):214–22.CrossRef
8.
go back to reference Dieleman JL, Baral R, Birger M, et al. US spending on personal health care and public health, 1996–2013. JAMA. 2016;316(24):2627–46.CrossRef Dieleman JL, Baral R, Birger M, et al. US spending on personal health care and public health, 1996–2013. JAMA. 2016;316(24):2627–46.CrossRef
9.
go back to reference Afshin A, Micha R, Khatibzadeh S, et al. The impact of dietary habits and metabolic risk factors on cardiovascular and diabetes mortality in countries of the Middle East and North Africa in 2010: a comparative risk assessment analysis. BMJ Open. 2015;5(5):e006385.CrossRef Afshin A, Micha R, Khatibzadeh S, et al. The impact of dietary habits and metabolic risk factors on cardiovascular and diabetes mortality in countries of the Middle East and North Africa in 2010: a comparative risk assessment analysis. BMJ Open. 2015;5(5):e006385.CrossRef
10.
go back to reference Rehm CD, Peñalvo JL, Afshin A, Mozaffarian D. Dietary intake among us adults, 1999–2012. JAMA. 2016;315(23):2542–53.CrossRef Rehm CD, Peñalvo JL, Afshin A, Mozaffarian D. Dietary intake among us adults, 1999–2012. JAMA. 2016;315(23):2542–53.CrossRef
11.
go back to reference Boyle JP, Honeycutt AA, Narayan KMV, et al. Projection of diabetes burden through 2050. Diabetes Care. 2001;24(11):1936–40.CrossRef Boyle JP, Honeycutt AA, Narayan KMV, et al. Projection of diabetes burden through 2050. Diabetes Care. 2001;24(11):1936–40.CrossRef
12.
go back to reference Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008;88(11):1254–64.CrossRef Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008;88(11):1254–64.CrossRef
13.
go back to reference Shrestha SS, Thompson TJ, Kirtland KA, et al. Changes in Disparity in County-Level Diagnosed Diabetes Prevalence and Incidence in the United States, between 2004 and 2012. PLOS ONE. 2016;11(8):e0159876.CrossRef Shrestha SS, Thompson TJ, Kirtland KA, et al. Changes in Disparity in County-Level Diagnosed Diabetes Prevalence and Incidence in the United States, between 2004 and 2012. PLOS ONE. 2016;11(8):e0159876.CrossRef
14.
go back to reference Myers CA, Slack T, Broyles ST, Heymsfield SB, Church TS, Martin CK. Diabetes prevalence is associated with different community factors in the diabetes belt versus the rest of the United States. Obesity. 2017;25(2):452–9.CrossRef Myers CA, Slack T, Broyles ST, Heymsfield SB, Church TS, Martin CK. Diabetes prevalence is associated with different community factors in the diabetes belt versus the rest of the United States. Obesity. 2017;25(2):452–9.CrossRef
15.
go back to reference Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, et al. US county-level trends in mortality rates for major causes of death, 1980–2014. JAMA. 2016;316(22):2385.CrossRef Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, et al. US county-level trends in mortality rates for major causes of death, 1980–2014. JAMA. 2016;316(22):2385.CrossRef
16.
go back to reference National Center for Health Statistics. National vital statistics system: mortality multiple cause—all counties files, 1980–2014. Hyattsville, MD: National Center for Health Statistics. National Center for Health Statistics. National vital statistics system: mortality multiple cause—all counties files, 1980–2014. Hyattsville, MD: National Center for Health Statistics.
18.
go back to reference National Center for Health Statistics. Vintage 2014 postcensal estimates of the resident population of the United States (April 1, 2010, July 1, 2010–July 1, 2014), by year, county, single-year of age (0, 1, 2, …, 85 years and over), bridged race, Hispanic origin, and sex. 2015. http://www.cdc.gov/nchs/nvss/bridged_race.htm. Accessed December 18, 2015. National Center for Health Statistics. Vintage 2014 postcensal estimates of the resident population of the United States (April 1, 2010, July 1, 2010–July 1, 2014), by year, county, single-year of age (0, 1, 2, …, 85 years and over), bridged race, Hispanic origin, and sex. 2015. http://​www.​cdc.​gov/​nchs/​nvss/​bridged_​race.​htm. Accessed December 18, 2015.
19.
go back to reference National Center for Health Statistics. Bridged-race intercensal estimates of the resident population of the United States for July 1, 1990-July 1, 1999, by year, county, single-year of age (0, 1, 2, …, 85 years and over), bridged race, Hispanic origin, and sex. 2004. http://www.cdc.gov/nchs/nvss/bridged_race.htm. Accessed November 21, 2011. National Center for Health Statistics. Bridged-race intercensal estimates of the resident population of the United States for July 1, 1990-July 1, 1999, by year, county, single-year of age (0, 1, 2, …, 85 years and over), bridged race, Hispanic origin, and sex. 2004. http://​www.​cdc.​gov/​nchs/​nvss/​bridged_​race.​htm. Accessed November 21, 2011.
20.
go back to reference National Center for Health Statistics. Bridged-race intercensal estimates of the resident population of the United States for July 1, 2000-July 1, 2009, by year, county, single-year of age (0, 1, 2, …, 85 years and over), bridged race, Hispanic origin, and sex. 2012. http://www.cdc.gov/nchs/nvss/bridged_race.htm. Accessed October 30, 2012. National Center for Health Statistics. Bridged-race intercensal estimates of the resident population of the United States for July 1, 2000-July 1, 2009, by year, county, single-year of age (0, 1, 2, …, 85 years and over), bridged race, Hispanic origin, and sex. 2012. http://​www.​cdc.​gov/​nchs/​nvss/​bridged_​race.​htm. Accessed October 30, 2012.
22.
go back to reference GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause and cause specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544.CrossRef GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause and cause specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544.CrossRef
23.
go back to reference Naghavi M, Makela S, Foreman K, O’Brien J, Pourmalek F, Lozano R. Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr. 2010;8:9.CrossRef Naghavi M, Makela S, Foreman K, O’Brien J, Pourmalek F, Lozano R. Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr. 2010;8:9.CrossRef
24.
go back to reference Leroux BG, Lei X, Breslow N. Estimation of disease rates in small areas: a new mixed model for spatial dependence. In: Statistical Models in Epidemiology, the Environment, and Clinical Trials. Vol 116. New York: Springer; 2000:179–191. Leroux BG, Lei X, Breslow N. Estimation of disease rates in small areas: a new mixed model for spatial dependence. In: Statistical Models in Epidemiology, the Environment, and Clinical Trials. Vol 116. New York: Springer; 2000:179–191.
25.
go back to reference Knorr-Held L. Bayesian modelling of inseparable space-time variation in disease risk. Stat Med. 2000;19(17–18):2555–67.CrossRef Knorr-Held L. Bayesian modelling of inseparable space-time variation in disease risk. Stat Med. 2000;19(17–18):2555–67.CrossRef
26.
go back to reference Kristensen K, Nielsen A, Berg CW, Skaug H, Bell B. TMB: automatic differentiation and Laplace approximation. J Stat Softw. 2016;70(5):1–21.CrossRef Kristensen K, Nielsen A, Berg CW, Skaug H, Bell B. TMB: automatic differentiation and Laplace approximation. J Stat Softw. 2016;70(5):1–21.CrossRef
27.
go back to reference Fienberg SE. An iterative procedure for estimation in contingency tables. Ann Math Stat. 1970;41(1):3. Fienberg SE. An iterative procedure for estimation in contingency tables. Ann Math Stat. 1970;41(1):3.
28.
go back to reference Dwyer-Lindgren L, Mackenbach JP, van Lenthe FJ, Flaxman AD, Mokdad AH. Diagnosed and undiagnosed diabetes prevalence by county in the US, 1999–2012. Diabetes Care. 2016;39(9):1556–62.CrossRef Dwyer-Lindgren L, Mackenbach JP, van Lenthe FJ, Flaxman AD, Mokdad AH. Diagnosed and undiagnosed diabetes prevalence by county in the US, 1999–2012. Diabetes Care. 2016;39(9):1556–62.CrossRef
29.
go back to reference Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1223–49.CrossRef Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1223–49.CrossRef
30.
go back to reference van Vark LC, Bertrand M, Akkerhuis KM, et al. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patients. Eur Heart J. 2012;33(16):2088–97.CrossRef van Vark LC, Bertrand M, Akkerhuis KM, et al. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patients. Eur Heart J. 2012;33(16):2088–97.CrossRef
31.
go back to reference Olives C, Myerson R, Mokdad AH, Murray CJL, Lim SS. Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001–2009. PLOS ONE. 2013;8(4):e60308.CrossRef Olives C, Myerson R, Mokdad AH, Murray CJL, Lim SS. Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001–2009. PLOS ONE. 2013;8(4):e60308.CrossRef
32.
go back to reference Herman WH, Ye W, Griffin SJ, et al. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe). Diabetes Care. 2015;38(8):1449–55.CrossRef Herman WH, Ye W, Griffin SJ, et al. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe). Diabetes Care. 2015;38(8):1449–55.CrossRef
33.
go back to reference Lasser KE, Himmelstein DU, Woolhandler S. Access to care, health status, and health disparities in the United States and Canada: results of a cross-national population-based survey. Am J Public Health. 2006;96(7):1300–7.CrossRef Lasser KE, Himmelstein DU, Woolhandler S. Access to care, health status, and health disparities in the United States and Canada: results of a cross-national population-based survey. Am J Public Health. 2006;96(7):1300–7.CrossRef
34.
go back to reference Narayan KMV, Gujral UP. Evidence tips the scale toward screening for hyperglycemia. Diabetes Care. 2015;38(8):1399–401.CrossRef Narayan KMV, Gujral UP. Evidence tips the scale toward screening for hyperglycemia. Diabetes Care. 2015;38(8):1399–401.CrossRef
35.
go back to reference National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60(5):850–86.CrossRef National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60(5):850–86.CrossRef
36.
go back to reference Dwyer-Lindgren L, Freedman G, Engell RE, et al. Prevalence of physical activity and obesity in US counties, 2001–2011: a road map for action. Popul Health Metr. 2013;11:7.CrossRef Dwyer-Lindgren L, Freedman G, Engell RE, et al. Prevalence of physical activity and obesity in US counties, 2001–2011: a road map for action. Popul Health Metr. 2013;11:7.CrossRef
37.
go back to reference Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014;384(9945):766–81.CrossRef Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014;384(9945):766–81.CrossRef
38.
go back to reference Dunkler D, Dehghan M, Teo KK, et al. Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med. 2013;173(18):1682–92.PubMed Dunkler D, Dehghan M, Teo KK, et al. Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med. 2013;173(18):1682–92.PubMed
39.
go back to reference Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–35.CrossRef Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–35.CrossRef
40.
go back to reference Mokdad AH. The behavioral risk factors surveillance system: past, present, and future. Annu Rev Public Health. 2009;30:43–54.CrossRef Mokdad AH. The behavioral risk factors surveillance system: past, present, and future. Annu Rev Public Health. 2009;30:43–54.CrossRef
41.
go back to reference Hoskin MA, Bray GA, Hattaway K, et al. Prevention of diabetes through the lifestyle intervention: lessons learned from the diabetes prevention program and outcomes study and its translation to practice. Curr Nutr Rep. 2014;3(4):364–78.CrossRef Hoskin MA, Bray GA, Hattaway K, et al. Prevention of diabetes through the lifestyle intervention: lessons learned from the diabetes prevention program and outcomes study and its translation to practice. Curr Nutr Rep. 2014;3(4):364–78.CrossRef
42.
go back to reference Li C, Barker L, Ford ES, Zhang X, Strine TW, Mokdad AH. Diabetes and anxiety in US adults: findings from the 2006 behavioral risk factor surveillance system. Diabet Med. 2008;25(7):878–81.CrossRef Li C, Barker L, Ford ES, Zhang X, Strine TW, Mokdad AH. Diabetes and anxiety in US adults: findings from the 2006 behavioral risk factor surveillance system. Diabet Med. 2008;25(7):878–81.CrossRef
43.
go back to reference Brown DW, Balluz LS, Giles WH, et al. Diabetes mellitus and health-related quality of life among older adults. Findings from the behavioral risk factor surveillance system (BRFSS). Diabetes Res Clin Pract. 2004;65(2):105–15.CrossRef Brown DW, Balluz LS, Giles WH, et al. Diabetes mellitus and health-related quality of life among older adults. Findings from the behavioral risk factor surveillance system (BRFSS). Diabetes Res Clin Pract. 2004;65(2):105–15.CrossRef
44.
go back to reference Pillay J, Armstrong MJ, Butalia S, et al. Behavioral programs for type 2 diabetes mellitus: a systematic review and network meta-analysis. Ann Intern Med. 2015;163(11):848–60.CrossRef Pillay J, Armstrong MJ, Butalia S, et al. Behavioral programs for type 2 diabetes mellitus: a systematic review and network meta-analysis. Ann Intern Med. 2015;163(11):848–60.CrossRef
45.
go back to reference Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, Morozoff C, Mackenbach JP, van Lenthe FJ, et al. Inequalities in life expectancy among US counties, 1980 to 2014: temporal trends and key drivers. JAMA Intern Med. 2017;177(7):1003–11.CrossRef Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, Morozoff C, Mackenbach JP, van Lenthe FJ, et al. Inequalities in life expectancy among US counties, 1980 to 2014: temporal trends and key drivers. JAMA Intern Med. 2017;177(7):1003–11.CrossRef
Metadata
Title
Trends and patterns of disparities in diabetes and chronic kidney disease mortality among US counties, 1980–2014
Authors
Ali H. Mokdad
Laura Dwyer-Lindgren
Amelia Bertozzi-Villa
Rebecca W. Stubbs
Chloe Morozoff
Shreya Shirude
Sam B. Finegold
Charlton Callender
Mohsen Naghavi
Christopher J. L. Murray
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Population Health Metrics / Issue 1/2022
Electronic ISSN: 1478-7954
DOI
https://doi.org/10.1186/s12963-022-00285-4

Other articles of this Issue 1/2022

Population Health Metrics 1/2022 Go to the issue